Propanc Biopharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PPCB

Propanc Biopharma Inc (PPCB) is developing proenzyme therapy to eliminate cancer stem cells, leading the market in R&D. Strict climate control during transportation ensures the reliability of the drugs. Insured contracts with carriers guarantee the continuity of trials. The operating profit trend demonstrates the company's actual earnings, with the parameter reaching 0.00.

Propanc Biopharma Inc. - Bathi operasional EBITDA PPCB (periode 23.11.2025 - 10.11.2026)

Propanc Biopharma (PPCB) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:

Rega bursa Propanc Biopharma Inc.|PPCB - Target konsensus

- rincian nilai pasar emiten:

Nilai pasar Propanc Biopharma|PPCB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- informasi kapitalisasi buku:

Rega Buku Saham Propanc Biopharma|PPCB - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku propanc.com|PPCB - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Propanc Biopharma Inc|PPCB - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Propanc Biopharma Inc.|PPCB - Gunggung utang perusahaan|Utang-utang marang nilai buku Propanc Biopharma|PPCB - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Propanc Biopharma|Likuiditas darurat propanc.com

- rincian asil keuangan lan kelipatan valuasi:

PPCB - Bathi resik|Prakiraan bathi resik Propanc Biopharma Inc|PPCB - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Propanc Biopharma Inc.|PPCB - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Propanc Biopharma|PPCB - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Propanc Biopharma|PPCB - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan propanc.com|PPCB - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Propanc Biopharma Inc

Ringkesan analitik perusahaan:Propanc Biopharma Inc

This indicator measures real cash flow from operating activities, excluding non-cash asset revaluations to verify the issuer's fundamental stability. By analyzing the trend of operating profit before interest and taxes, investors assess the ability of Propanc Biopharma Inc (PPCB) to monetize its unique proenzyme technology, which is critical for exercising pricing power within the inelastic demand segment for targeted cancer therapy.

Analisis pesaing Propanc Biopharma Inc

Genmab Corp (GMAB) - Bathi sadurunge bunga, pajak, lan amortisasi|EXEL: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NUVL (nuvalent.com)|KYMR (Kymera) - Bathi operasional sadurunge ngurangi amortisasi|IDYA: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ELVN (Enliven Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA ORIC Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Relay Therapeutics (RLAY)|NRIX (nurixtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TYRA (Tyra Biosciences)|Bathi operasional sadurunge potongan amortisasi Verastem Oncology|Monte Rosa Tx - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Cullinan Corp|IMRX (Immuneering Corporation) - Bathi operasional sadurunge ngurangi amortisasi|CCCC: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|BDTX (Black Diamond Therapeutics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Repare Therapeutics, Inc. RPTX|Bathi operasional EBITDA PMVP|karyopharm.com - Bathi operasional sadurunge amortisasi|Bio Green Med Solution Inc - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi AADI|ALRN: Bathi operasional sadurunge ngurangi amortisasi|Blueprint Medicines - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|GLYC: Bathi operasional EBITDA|SpringWorks Therapeutics, Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi